Software
delta
Advanced analytics platform designed with the user in mind
The Aurora and Apollo are perfectly paired with delta software, a suite of analytical tools that rapidly turn high-quality data into scientific insight. RedShiftBio's delta is a software platform designed with the user in mind, with an intuitive interface for simple operation, and advanced analytical performance this software provides critical insights into data with minimal training and user interaction.
Within the delta software there is a useful protein database, or a library of model proteins, using the spectral data from ongoing studies. This feature helps increase the relevance and accuracy of processed data by enabling the use of appropriate model proteins to analyze samples with unknown structures.
delta – 21 CFR Part 11 Compliance Upgrade
Data integrity and confidence when you need it most with 21 CFR
The delta software package can also be upgraded to support 21 CFR compliance, providing total confidence in data integrity within the regulated environment. Finally, there is a tool that can be used to bring protein structure to a Critical Quality Attribute (CQA) where it needs to be. Whether looking at batch-to-batch reproducibility, sample processing variations or lot release testing, the Aurora and Apollo can provide data to support your needs.
delta – 21 CFR Part 11 Compliance Upgrade
Data integrity and confidence when you need it most with 21 CFR
The delta software package can also be upgraded to support 21 CFR compliance, providing total confidence in data integrity within the regulated environment. Finally, there is a tool that can be used to bring protein structure to a Critical Quality Attribute (CQA) where it needs to be. Whether looking at batch-to-batch reproducibility, sample processing variations or lot release testing, the Aurora and Apollo can provide data to support your needs.
Accessories
Request a Demo Today!
MMS offers unparalleled efficiency in bioprocess analytics, allowing for real-time protein concentration monitoring and minimizing workflow disruptions. This provides researchers and biopharmaceutical manufacturers with faster, more reliable structural insights to optimize formulation and stability studies.
